By harnessing the full force of a patient's immune system, the targeted approach of CAR T-cell therapy makes it possible to mount a highly effective attack against certain cancers. Dr. Robert Collins, Director of UT Southwestern’s Blood Cancers Program and a leader in immunotherapy, explains how advances in this field offer hope to pediatric and adult cancer patients.
